Surabhi Shukla

511 total citations
7 papers, 380 citations indexed

About

Surabhi Shukla is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Surabhi Shukla has authored 7 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 1 paper in Organic Chemistry. Recurrent topics in Surabhi Shukla's work include Histone Deacetylase Inhibitors Research (2 papers), Nuclear Receptors and Signaling (2 papers) and Protein Degradation and Inhibitors (2 papers). Surabhi Shukla is often cited by papers focused on Histone Deacetylase Inhibitors Research (2 papers), Nuclear Receptors and Signaling (2 papers) and Protein Degradation and Inhibitors (2 papers). Surabhi Shukla collaborates with scholars based in United States. Surabhi Shukla's co-authors include Babu L. Tekwani, Babu L. Tekwani, Zia Shariat‐Madar, Larry Walker, Narayan D. Chaurasiya, XiangDi Wang, Alekha K. Dash, Bharathi Avula, Karthik Yadav Janga and Ikhlas A. Khan and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Frontiers in Pharmacology and Molecular and Cellular Neuroscience.

In The Last Decade

Surabhi Shukla

7 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Surabhi Shukla United States	6	215	87	71	65	54	7	380
Yoo Hun Noh South Korea	9	151 0.7×	93 1.1×	42 0.6×	43 0.7×	61 1.1×	16	404
Rosalva Thereza Meurer Brazil	6	199 0.9×	60 0.7×	81 1.1×	111 1.7×	41 0.8×	7	423
Z. Xiang China	6	100 0.5×	119 1.4×	67 0.9×	51 0.8×	82 1.5×	17	328
Hongrong Xie China	8	320 1.5×	65 0.7×	116 1.6×	104 1.6×	50 0.9×	10	554
Stefania Ippati Italy	13	148 0.7×	204 2.3×	79 1.1×	59 0.9×	56 1.0×	20	399
Yuko Saito Japan	13	319 1.5×	131 1.5×	74 1.0×	70 1.1×	19 0.4×	41	514
Edgar Dawkins Australia	9	174 0.8×	214 2.5×	121 1.7×	81 1.2×	71 1.3×	10	428
Limor Avrahami Israel	8	268 1.2×	164 1.9×	44 0.6×	71 1.1×	53 1.0×	9	484
Kavita Vats India	9	208 1.0×	149 1.7×	84 1.2×	42 0.6×	33 0.6×	22	440
Zongbo Zhao China	9	278 1.3×	76 0.9×	73 1.0×	74 1.1×	36 0.7×	11	432

Countries citing papers authored by Surabhi Shukla

Since Specialization

Citations

This map shows the geographic impact of Surabhi Shukla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surabhi Shukla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surabhi Shukla more than expected).

Fields of papers citing papers by Surabhi Shukla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surabhi Shukla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surabhi Shukla. The network helps show where Surabhi Shukla may publish in the future.

Co-authorship network of co-authors of Surabhi Shukla

This figure shows the co-authorship network connecting the top 25 collaborators of Surabhi Shukla. A scholar is included among the top collaborators of Surabhi Shukla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surabhi Shukla. Surabhi Shukla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Dash, Alekha K., et al.. (2025). Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders. Pharmaceuticals. 18(1). 87–87. 2 indexed citations

2.

Shukla, Surabhi, et al.. (2021). Liposome based drug delivery as a potential treatment option for Alzheimer’s disease. Neural Regeneration Research. 17(6). 1190–1190. 47 indexed citations

3.

Shukla, Surabhi & Babu L. Tekwani. (2020). Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation. Frontiers in Pharmacology. 11. 537–537. 211 indexed citations

4.

Shukla, Surabhi, et al.. (2020). Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis. Pharmaceuticals. 14(1). 29–29. 87 indexed citations

5.

Janga, Karthik Yadav, Akshaya Tatke, Surabhi Shukla, et al.. (2018). Retina Compatible Interactions and Effective Modulation of Blood Ocular Barrier P-gp Activity by Third-Generation Inhibitors Improve the Ocular Penetration of Loperamide. Journal of Pharmaceutical Sciences. 107(8). 2128–2135. 9 indexed citations

6.

Chaurasiya, Narayan D., Surabhi Shukla, & Babu L. Tekwani. (2017). A Combined In Vitro Assay for Evaluation of Neurotrophic Activity and Cytotoxicity. SLAS DISCOVERY. 22(6). 667–675. 9 indexed citations

7.

Shukla, Surabhi, Zia Shariat‐Madar, Larry Walker, & Babu L. Tekwani. (2016). Mechanism for neurotropic action of vorinostat, a pan histone deacetylase inhibitor. Molecular and Cellular Neuroscience. 77. 11–20. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact